F Skobieranda: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Preference Comparison of Rizatriptan ODT 10-mg and Sumatriptan 50-mg Tablet in Migraine

Elizabeth Loder, Jan Lewis Brandes, Stephen Silberstein, Franck Skobieranda, Norman Bohidar, Lixia Wang, Denise Boyle, Andrea Kolodny, Filippa Guerra, Nancy Santanello, Lisa Johnson-Pratt, the Rizatri

Journal:

Headache: The Journal of Head and Face Pain

Year:

2001

Language:

english

File:

PDF, 67 KB

english, 2001

2

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: Six-month comparison of efficacy and tolerability

Kenneth N Sall, Linda J Greff, Lisa R Johnson-Pratt, Paul T DeLucca, Adam B Polis, Andrea H Kolodny, Charlena A Fletcher, Deborah A Cassel, Denise R Boyle, Franck Skobieranda

Journal:

Year:

2003

Language:

english

File:

PDF, 141 KB

english, 2003

3

Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets

A Kolodny, A Polis, WP Battisti, L Johnson-Pratt, F Skobieranda, the Rizatriptan Protocol 052 Study Group

Journal:

Year:

2004

Language:

english

File:

PDF, 74 KB

english, 2004

4

Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies

LK Mannix, E Loder, R Nett, L Mueller, A Rodgers, CM Hustad, KE Ramsey, F Skobieranda

Journal:

Year:

2007

Language:

english

File:

PDF, 232 KB

english, 2007

5

Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies

R Cady, V Martin, A Mauskop, A Rodgers, CM Hustad, KE Ramsey, F Skobieranda

Journal:

Year:

2007

Language:

english

File:

PDF, 161 KB

english, 2007

6

Efficacy of Rizatriptan 10 mg Administered Early in a Migraine Attack

Roger Cady, Vincent Martin, Alexander Mauskop, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey, Franck Skobieranda

Journal:

Headache: The Journal of Head and Face Pain

Year:

2006

Language:

english

File:

PDF, 253 KB

english, 2006

7

Comment on Eletriptan in Migraine Patients Reporting Unsatisfactory Response to Rizatriptan

Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey, Franck Skobieranda

Journal:

Headache: The Journal of Head and Face Pain

Year:

2007

Language:

english

File:

PDF, 68 KB

english, 2007

8

Elimination of Migraine-Associated Nausea in Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT): A Randomized, Double-Blind, Placebo-Controlled Study

Fred Freitag, Frederick R. Taylor, Mohammed A. Hamid, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey, Franck Skobieranda

Journal:

Headache: The Journal of Head and Face Pain

Year:

2008

Language:

english

File:

PDF, 216 KB

english, 2008

9

Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies

Vincent Martin, Roger Cady, Alexander Mauskop, Larry S. Seidman, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey, Franck Skobieranda

Journal:

Headache: The Journal of Head and Face Pain

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

10

Efficacy and Tolerability of Coadministration of Rizatriptan and Acetaminophen vs Rizatriptan or Acetaminophen Alone for Acute Migraine Treatment

Fred Freitag, Merle Diamond, Seymour Diamond, Imke Janssen, Anthony Rodgers, Franck Skobieranda

Journal:

Headache: The Journal of Head and Face Pain

Year:

2008

Language:

english

File:

PDF, 224 KB

english, 2008

11

Quality of Life and Well-Being of Headache Patients: Measurement by the Medical Outcomes Study Instrument

Glen D. Solomon, Franck G. Skobieranda, Lisa A. Gragg

Journal:

Headache: The Journal of Head and Face Pain

Year:

1993

Language:

english

File:

PDF, 108 KB

english, 1993

12

Does Quality of Life Differ Among Headache Diagnoses? Analysis Using the Medical Outcomes Study Instrument

Glen D. Solomon, Franck G. Skobieranda, Lisa A. Gragg

Journal:

Headache: The Journal of Head and Face Pain

Year:

1994

Language:

english

File:

PDF, 76 KB

english, 1994

13

Quality of Life Assessment Among Migraine Patients Treated With Sumatriptan

Glen D. Solomon, Franck G. Skobieranda, Jonathan R. Genzen

Journal:

Headache: The Journal of Head and Face Pain

Year:

1995

Language:

english

File:

PDF, 259 KB

english, 1995

14

Rizatriptan Efficacy in ICHD-II Pure Menstrual Migraine and Menstrually Related Migraine

Robert Nett, Lisa K. Mannix, Loretta Mueller, Anthony Rodgers, Carolyn M. Hustad, Franck Skobieranda, Karen E. Ramsey

Journal:

Headache: The Journal of Head and Face Pain

Year:

2008

Language:

english

File:

PDF, 149 KB

english, 2008

15

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

Wenzel, Sally, Ford, Linda, Pearlman, David, Spector, Sheldon, Sher, Lawrence, Skobieranda, Franck, Wang, Lin, Kirkesseli, Stephane, Rocklin, Ross, Bock, Brian, Hamilton, Jennifer, Ming, Jeffrey E., R

Journal:

Boston Medical and Surgical Journal

Year:

2013

Language:

english

File:

PDF, 848 KB

english, 2013

16

(478) TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers

Soergel, D., Subach, R., James, I., Violin, J., Skobieranda, F., Sadler, B., Burnham, N., Theisen, T., Lark, M., Webster, L.

Journal:

The Journal of Pain

Year:

2014

Language:

english

File:

PDF, 94 KB

english, 2014

17

Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers

Soergel, David G., Subach, Ruth Ann, Burnham, Nancy, Lark, Michael W., James, Ian E., Sadler, Brian M., Skobieranda, Franck, Violin, Jonathan D., Webster, Lynn R.

Journal:

Year:

2014

Language:

english

File:

PDF, 481 KB

english, 2014

18

Persistent positive visual phenomena in migraine

Liu, G. T., Schatz, N. J., Galetta, S. L., Volpe, N. J., Skobieranda, F., Kosmorsky, G. S.

Journal:

Year:

1995

Language:

english

File:

PDF, 606 KB

english, 1995

19

Evaluation of an Adaptive Maximizing Design Study Based on Clinical Utility Versus Morphine for TRV130 Proof-of-Concept and Dose-Regimen Finding in Patients With Postoperative Pain After Bunionectomy

Bolognese, J. A., Subach, R. A., Skobieranda, F.

Journal:

Therapeutic Innovation & Regulatory Science

Year:

2015

Language:

english

File:

PDF, 323 KB

english, 2015

20

Pharmacokinetic Profile of Rizatriptan 10-mg Tablet and 10-mg Orally Disintegrating Tablet Administered With or Without Water in Healthy Subjects: An Open-Label, Randomized, Single-Dose, 3-Period Crossover Study

Swan, Suzanne K., Alcorn, Harry, Rodgers, Anthony, Hustad, Carolyn M., Ramsey, Karen E., Woll, Susan, Skobieranda, Franck

Journal:

Journal of Clinical Pharmacology

Year:

2006

Language:

english

File:

PDF, 105 KB

english, 2006

21

Do Patients With Obstructive Sleep Apnea Wake Up With Headaches?

Loh, N. K., Dinner, D. S., Foldvary, N., Skobieranda, F., Yew, W. W.

Journal:

Archives of Internal Medicine

Year:

1999

Language:

english

File:

PDF, 156 KB

english, 1999

22

Efficacy of Rizatriptan for Menstrual Migraine in the Treat A Migraine Early (TAME) Studies

Martin, Vincent, Cady, Roger, Mauskop, Alexander, Seidman, Larry S., Rodger, Anthony, Skobieranda, Franck

Journal:

Obstetrics & Gynecology

Year:

2006

Language:

english

File:

PDF, 302 KB

english, 2006

23

(342) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. I: development of a pharmacokinetic/pharmacodynamic (PK/PD) model

Fossler, M., Sadler, B., Farrell, C., Burt, D., Pitsiu, M., Skobieranda, F., Soergel, D.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 38 KB

english, 2016

24

(435) Nausea and vomiting with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs morphine: an analysis of tolerability from a phase 2b randomized clinical trial

Minkowitz, H., Singla, N., Soergel, D., Burt, D., Skobieranda, F.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 35 KB

english, 2016

25

(433) Rapid reduction in pain intensity with oliceridine (TRV130), a novel μ receptor G protein Pathway Selective modulator (μ-GPS), vs. Morphine: an analysis of two phase 2 randomized clinical trials

Viscusi, E., Minkowitz, H., Webster, L., Soergel, D., Burt, D., Subach, R., Skobieranda, F.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 51 KB

english, 2016

26

Dorzolamide/Timolol Fixed Combination Versus Concomitant Administration of Brimonidine and Timolol in Patients with Elevated Intraocular Pressure

Solish, Alfred M., DeLucca, Paul T., Cassel, Deborah A., Kolodny, Andrea H., Hustad, Carolyn M., Skobieranda, Franck

Journal:

Journal of Glaucoma

Year:

2004

Language:

english

File:

PDF, 98 KB

english, 2004

27

(343) Oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), demonstrates a predictable relationship between plasma concentrations and pain relief. II: simulation of potential dosing regimens using a pharmacokinetic/pharmacodynamic (PK/PD) model

Fossler, M., Sadler, B., Farrell, C., Burt, D., Pitsiu, M., Skobieranda, F., Soergel, D.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 38 KB

english, 2016

28

(432) Respiratory safety signal with oliceridine (TRV130), a novel μ receptor G protein pathway selective modulator (μ-GPS), vs morphine: a safety analysis of a Phase 2b randomized clinical trial

Singla, N., Minkowitz, H., Soergel, D., Burt, D., Skobieranda, F.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 39 KB

english, 2016

29

Decreased Expression of the Human Progenitor Cell Antigen (CD34) in Morphea

Skobieranda, Kathe, Helm, Klaus F.

Journal:

American Journal of Dermatopathology

Year:

1995

File:

PDF, 331 KB

1995

30

A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain

Viscusi, Eugene R., Webster, Lynn, Kuss, Michael, Daniels, Stephen, Bolognese, James A., Zuckerman, Seth, Soergel, David G., Subach, Ruth Ann, Cook, Emily, Skobieranda, Franck

Journal:

Year:

2016

Language:

english

File:

PDF, 720 KB

english, 2016

31

Dose Interruptions with Morphine vs Oliceridine (TRV130), a Novel μ Receptor G Protein Pathway Selective (μ-GPS) Modulator: Analysis from a Placebo- and Morphine-Controlled Phase 2b Study in Patients Following Abdominoplasty

Senagore, Anthony J., Soergel, David, Burt, David, Skobieranda, Franck, Singla, Neil

Journal:

Journal of the American College of Surgeons

Year:

2016

Language:

english

File:

PDF, 97 KB

english, 2016

32

(223) APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy

Skobieranda, F., Singla, N., Burt, D., Soergel, D.

Journal:

The Journal of Pain

Year:

2017

Language:

english

File:

PDF, 293 KB

english, 2017

33

I2. Rapid Onset of Pain Relief with Oliceridine (TRV130) vs. Morphine: a Phase 2a/b Study Analysis

Soergel, David, Viscusi, Eugene, Webster, Lynn, Burt, David, Skobieranda, Franck

Journal:

Pain Management Nursing

Year:

2017

Language:

english

File:

PDF, 43 KB

english, 2017

34

I1. A Randomized, Placebo- and Active-Controlled Phase 2b Study Investigating Oliceridine (TRV130)

Soergel, David, Minkowitz, Harold, Burt, David, Skobieranda, Franck

Journal:

Pain Management Nursing

Year:

2017

Language:

english

File:

PDF, 55 KB

english, 2017

35

Gastrointestinal Tolerability With Oliceridine, A Novel µ Receptor G Protein Pathway Selective (µ-GPS) Modulator [4H]

Steinberg, Adam C., Soergel, David, Burt, David, Skobieranda, Franck

Journal:

Obstetrics & Gynecology

Year:

2017

Language:

english

File:

PDF, 151 KB

english, 2017

36

Oliceridine, a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. II: Simulation of Potential Phase 3 Study Designs Using a Pharmacokinetic/Pharmacodynamic Model

Fossler, Michael J., Sadler, Brian M., Farrell, Colm, Burt, David A., Pitsiu, Maria, Skobieranda, Franck, Soergel, David G.

Journal:

Journal of Clinical Pharmacology

Year:

2018

Language:

english

File:

PDF, 971 KB

english, 2018

37

Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model

Fossler, Michael J., Sadler, Brian M., Farrell, Colm, Burt, David A., Pitsiu, Maria, Skobieranda, Franck, Soergel, David G.

Journal:

Journal of Clinical Pharmacology

Year:

2018

Language:

english

File:

PDF, 940 KB

english, 2018

38

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

Singla, Neil, Minkowitz, Harold, Soergel, David, Burt, David, Subach, Ruth Ann, Salamea, Monica, Fossler, Michael, Skobieranda, Franck

Journal:

Journal of Pain Research

Year:

2017

Language:

english

File:

PDF, 393 KB

english, 2017

39

APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

Viscusi, Eugene R, Skobieranda, Franck, Soergel, David G, Cook, Emily, Burt, David A, Singla, Neil

Journal:

Journal of Pain Research

Year:

2019

Language:

english

File:

PDF, 1.57 MB

english, 2019

40

APOLLO ‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine ( TRV 130), a G Protein‐Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty

Singla, Neil K., Skobieranda, Franck, Soergel, David G., Salamea, Monica, Burt, David A., Demitrack, Mark A., Viscusi, Eugene R.

Journal:

Year:

2019

Language:

english

File:

PDF, 1.34 MB

english, 2019

41

A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor

James, Ian E., Skobieranda, Franck, Soergel, David G., Ramos, Kimberly A., Ruff, Dennis, Fossler, Michael J.

Journal:

Clinical Pharmacology in Drug Development

Year:

2019

Language:

english

File:

PDF, 815 KB

english, 2019

42

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine

Nafziger, Anne N., Arscott, Kelly A., Cochrane, Kristina, Skobieranda, Franck, Burt, David A., Fossler, Michael J.

Journal:

Clinical Pharmacology in Drug Development

Year:

2019

Language:

english

File:

PDF, 527 KB

english, 2019

43

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine

Nafziger, Anne N., Arscott, Kelly A., Cochrane, Kristina, Skobieranda, Franck, Burt, David A., Fossler, Michael J.

Journal:

Clinical Pharmacology in Drug Development

Year:

2019

File:

PDF, 527 KB

2019

44

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy

Bogan, Richard K, Thorpy, Michael J, Dauvilliers, Yves, Partinen, Markku, Del Rio Villegas, Rafael, Foldvary-Schaefer, Nancy, Skowronski, Roman, Tang, Lihua, Skobieranda, Franck, Å onka, Karel

Journal:

Year:

2020

File:

PDF, 285 KB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски